Company Profile

Belluscura PLC is a United Kingdom-based medical device developer company. The Company is focused on developing lightweight and portable oxygen enrichment technology. The Company's product X-PLOR, is a modular portable oxygen concentrator. The X-PLOR is lightweight, specifically designed to replace metal oxygen tanks and heavier portable oxygen concentrator devices. The X-PLOR can deliver up to 95% pure oxygen to patients 24 hours a day, seven days a week. The Company is focused on developing medical devices who suffer from chronic lung diseases, such as the Chronic Obstructive Pulmonary Disease (COPD), respiratory distress caused by COVID-19, and many other respiratory disorders. It is also focused on developing, licensing and manufacturing portable oxygen concentrators for use in treating lung diseases with its oxygen platform technologies, to include recreational and industrial oxygen concentrators, wound care devices, drug delivery devices and more.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

01/10/25	EARNINGS: Next 15 profit falls; 4basebio and Mollyroe losses widen	AN
22/09/25	Belluscura plc Announces Termination of Robert Rauker as Director, Effective September 22, 2025	CI
22/09/25	Belluscura plc Announces Termination of Appointment of Richard John Piper as Director, Effective September 22, 2025	CI
22/09/25	Belluscura plc Announces Termination of Appointment of Simon Neicheril as Director, Effective May 2, 2025	CI
22/09/25	Belluscura Unit Cuts 15 US Jobs Amid Refinancing Talks	MT
22/09/25	Belluscura says proposed fundraising talks not yet concluded as anticipated	RE
12/09/25	Belluscura plc Announces Appointment of Guy Peters as Non-Executive Director, Effective September 11, 2025	CI
11/08/25	Metals One takes stake in CleanTech Lithium	AN
11/08/25	Belluscura to Potentially Dispose of Certain Medical Assets, Liabilities; Loan Note Deal Terminated	MT
30/06/25	EARNINGS AND TRADING: TT Electronics revenue falls; Capai in profit	AN
30/06/25	Belluscura Unit Obtains Short-term Convertible Loan Note	MT
30/06/25	Belluscura plc Provides Strategic Review Update	CI
26/05/25	Firms Scrap Forecasts Under Tariff Strain

26/05/25	Firms Scrap Forecasts Under Tariff Strain
12/07/24	Stonegate Updates Coverage on Belluscura PLC (BELL) 4Q23	NE
02/11/23	Killik & Co. LLP - Form 8.3 - Belluscura Plc	PR
20/10/23	Stonegate Initiates Coverage on Belluscura PLC (BELL)	NE

Manager	Title	Age	Since
Robert Rauker CEO	Chief Executive Officer	-	17/08/2016
Brian Brown COO	Chief Operating Officer	-	-
Jim Clement PRN	Corporate Officer/Principal	-	04/04/2022

Director	Title	Age	Since
Paul Tuson CHM	Chairman	59	-
Guy Peters BRD	Director/Board Member	64	11/09/2025

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
BELLUSCURA PLC	-.--%	+3.45%	-	-	4.02M
ABBOTT LABORATORIES	-2.36%	-2.50%	-19.44%	-3.28%	179B
MEDTRONIC PLC	-0.80%	+0.67%	+5.66%	+8.69%	113B
CENCORA, INC.	-0.51%	-1.23%	+14.93%	+92.82%	62.73B
HOYA CORPORATION	+1.74%	+6.94%	+89.04%	+108.41%	61.09B
BECTON, DICKINSON AND COMPANY	-0.80%	-0.19%	-22.55%	-39.17%	44.27B
MEDLINE INC.	-0.20%	+2.98%	-	-	37.08B
DEXCOM, INC.	-2.53%	+2.89%	-4.87%	-43.11%	25.28B
STERIS PLC	-0.52%	+1.77%	+2.51%	+15.78%	21.94B
TERUMO CORPORATION	-1.47%	-1.97%	-25.20%	+15.90%	20.12B
Average	-0.56%	+1.60%	+5.01%	+19.51%	62.7B
Weighted average by Cap.	-0.45%	+1.22%	+3.73%	+20.26%

Belluscura plc Share Price

Equities

BELL

GB00BD3B8Z11

Medical Equipment, Supplies & Distribution

Chart: Belluscura plc

Latest news: Belluscura plc

Analysts' recommendations: Belluscura plc

Press Releases: Belluscura plc

News in other languages: Belluscura plc

Managers and Directors: Belluscura plc

Other Medical Equipment, Supplies & Distribution

Company Profile